Ning Jiang, Ming Jiang, Xiangzhi Zhu, Feng Jiang, Wei Ren, Guochun Cao, Cheng Chen, Jingfeng Mei, Yixin Li, Qishu Tan, Yidan Hong, Zhen Guo, Jingyuan Zhang, Xiaochen Huang, Yang Zhao. "Tislelizumab plus short-course chemo-radiotherapy for conversion therapy of unresectable ESCC (LATE): A proof-of-concept, phase Ib trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16119